Yes. Fasting lowers blood glucose in most people, but the size and timing of the drop depend on how long you fast, what your liver is doing, and how much insulin your body can still make. In people without diabetes, glucose usually settles into a narrow band between roughly 70 and 99 mg/dL after 8 to 12 hours without food. In people with diabetes, the response can swing from mild to dangerous depending on medications.
The mechanism: why glucose falls, then holds steady
Blood glucose during fasting is not a passive slide. It is an active tug-of-war between supply and demand, and the referee is insulin.
After a meal, insulin tells muscle and fat to take up glucose and tells the liver to stop releasing it. When you stop eating, insulin falls. That drop releases the brake on the liver, which begins breaking down stored glycogen and releasing glucose into the blood. This is glycogenolysis, and it is the main reason fasting glucose does not crash to zero. The liver holds roughly 100 grams of glycogen in a typical adult, enough to supply glucose for about 12 to 24 hours of fasting depending on body size and activity.
As glycogen runs low, the body shifts. The liver starts making new glucose from lactate, glycerol, and amino acids, a process called gluconeogenesis. Fat breakdown supplies free fatty acids, which muscle and other tissues burn instead of glucose. This spares what glucose remains for the brain, which cannot burn fat directly. The brain instead uses ketones, produced from fat in the liver, for a growing share of its energy as fasting continues.
The counterintuitive detail: fasting glucose can rise slightly the longer you fast in some people. Falling insulin and rising counter-regulatory hormones such as glucagon, cortisol, and growth hormone push the liver to release more glucose. So a 24-hour fast may show a higher morning glucose than a 14-hour fast in the same person, not because fasting failed but because the liver is defending the brain's fuel supply.
How much does glucose actually drop, and when?
The fall is fastest in the first hours after a meal ends, then flattens into a defended plateau. The timeline table below summarizes typical patterns in adults without diabetes.
| Time fasting | Approximate blood glucose (mg/dL) | Dominant physiology |
|---|---|---|
| 0 to 2 hours (post-meal) | 100 to 140, then falling | Insulin high, liver uptake of glucose |
| 2 to 4 hours | 90 to 110 | Insulin falling, early glycogenolysis |
| 4 to 8 hours | 80 to 100 | Glycogenolysis dominant, stable plateau |
| 8 to 12 hours | 70 to 99 | Gluconeogenesis rising, ketones beginning |
| 12 to 18 hours | 65 to 95 | Ketones up, fat oxidation dominant |
| 18 to 24 hours | 60 to 90, occasional small rises | Gluconeogenesis and ketosis established |
| 24 to 48 hours | 55 to 85, individual variability | Ketones supplying much of brain fuel |
These ranges describe healthy adults. They are not treatment targets and not predictions for anyone with diabetes or on glucose-lowering medication.
For context on scale: fasting glucose above 100 mg/dL but below 126 mg/dL is classified as impaired fasting glucose, a prediabetes range, according to American Diabetes Association criteria. A fasting glucose of 126 mg/dL or higher on two occasions supports a diabetes diagnosis. These thresholds are diagnostic, not fasting-duration guidelines, but they explain why a single 12-hour fasting reading is used clinically.
Edge cases where fasting behaves differently
The same fast can produce opposite glucose results in different people. Four groups stand out.
People with type 1 diabetes have little or no endogenous insulin. Without insulin, the liver releases glucose unchecked, and fasting can produce rising glucose (dawn phenomenon) rather than a fall. Injected insulin doses that were calibrated for fed states can also cause hypoglycemia during long fasts. This is a medication-management problem, not a fasting problem, and it requires a clinician.
People with type 2 diabetes sit on a spectrum. Early in the disease, fasting may lower glucose modestly. With advanced disease and reduced insulin secretion, the liver's glucose output can stay elevated even when fasting, so glucose plateaus high instead of falling. This is a key professional caveat: fasting is not uniformly glucose-lowering in type 2 diabetes.
People taking sulfonylureas or meglitinides face a specific risk. These drugs stimulate insulin release regardless of glucose level, so fasting removes the meal that would normally buffer the extra insulin. The result can be hypoglycemia within hours. Insulin secretagogues plus prolonged fasting is a recognized hazard, and dose adjustment is a clinical decision.
People on GLP-1 receptor agonists or SGLT2 inhibitors have different risk profiles. SGLT2 inhibitors lower glucose by promoting urinary glucose loss, and they carry a rare but serious risk of euglycemic ketoacidosis during prolonged fasting or illness, where glucose is near normal but ketones are dangerously high. This is a red flag that a normal glucose reading does not rule out.
Misconceptions worth correcting
The most common misconception is that longer fasting always means lower glucose. The liver's counter-regulatory response makes this false beyond roughly 18 to 24 hours in many people, and glucose can stabilize or tick up.
A second misconception is that fasting glucose reflects only diet. It reflects liver glucose output, insulin sensitivity, stress hormones, sleep, and illness. A single high fasting reading can follow a poor night's sleep or an infection.
A third is that fasting "resets" glucose in diabetes. Fasting can improve insulin sensitivity over weeks when combined with weight loss, but it is not a substitute for medication adjustment, and it can be unsafe in type 1 diabetes and in people on insulin or sulfonylureas without supervision.
A timeline for a first fasted-morning measurement
The table above already covers the physiology. For practical measurement, the useful anchor is the 8-to-12-hour mark, which is the window clinical fasting glucose tests assume. A reading taken at 14 hours is not wrong, but it is not the same measurement as a standard fasting glucose and should not be compared against the 100 and 126 mg/dL diagnostic cutoffs.
Practical actions: what to do with this
Use concrete steps, and treat thresholds as decision points, not diagnoses.
Measure at a consistent fasting duration. Eight to twelve hours is the standard clinical window. Pick one duration and compare like with like. Track three numbers, not one: fasting glucose, a 2-hour post-meal value, and the difference between them. The gap shows how well your body handles a glucose load. Treat a fasting glucose of 100 to 125 mg/dL as a prompt to get an A1c and a clinician's review, not a self-diagnosis. Treat any glucose below 70 mg/dL as hypoglycemia. Stop the fast, consume 15 grams of fast-acting carbohydrate, and recheck in 15 minutes. If you take insulin or a sulfonylurea, treat this as a medical event and discuss medication timing with your clinician. Do not extend a fast past 24 hours to "push glucose lower." The physiology does not support the goal, and the risk rises. Red flags that end the fast immediately: confusion, shakiness, sweating, palpitations, nausea with normal glucose (possible ketoacidosis on an SGLT2 inhibitor), or glucose below 54 mg/dL.
Limits of what fasting data can tell you
Fasting glucose is one snapshot of a dynamic system. It does not measure insulin resistance directly, does not capture post-meal spikes, and does not distinguish between a liver that is releasing too much glucose and a pancreas that is releasing too little insulin. Those distinctions require insulin assays and clinical evaluation.
The evidence for fasting as a glucose-lowering strategy is strongest for time-restricted eating with weight loss, where improvements in fasting glucose track with fat loss rather than fasting duration alone. The cleanest conclusion is mechanistic: fasting lowers glucose by removing dietary input and shifting fuel use, then defends glucose through liver output. How far it falls, and whether that is safe, depends on insulin status and medication. Anyone with diabetes, on insulin, or on a sulfonylurea should not change fasting habits without clinical guidance.